References
- Gleeson P. A., Toh B. H., van Driel I. R. “Organ-specific autoimmunity induced by lymphopenia”. Immunol. Rev. 1996; 149: 97–125
- Asano M., Toda M., Sakaguchi N., Sakaguchi S. “Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation”. J. Exp. Med. 1996; 184: 387–396
- Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. “Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25)”. J. Immunol. 1995; 155: 1151–1164
- Sakaguchi S. “Regulatory T cells: key controllers of immunologic self-tolerance”. Cell 2000; 101: 455–458
- Shevach E. M. “Regulatory T cells in autoimmunity”. Annu. Rev. Immunol. 2000; 18: 423–449
- Suri-Payer E., Amar A. Z., Thornton A. M., Shevach E. M. “CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells”. J. Immunol. 1998; 160: 1212–1218
- Murakami K., Maruyama H., Hosono M., Yamada J., Kuribayashi K., Masuda T. “Germ-free condition and the susceptibility of BALB/c mice to post-thymectomy autoimmune gastritis”. Autoimmunity 1992; 12: 69–70
- Medzhitov R., Janeway C. A., Jr. “Innate immunity: impact on the adaptive immune response”. Curr. Opin. Immunol. 1997; 9: 4–9
- Bancroft G. J. “The role of natural killer cells in innate resistance to infection”. Curr. Opin. Immunol. 1993; 5: 503–510
- Romagnani S. “Induction of Thl and Th2 responses– a key role for the natural immune response”. Immunol. Today 1992; 13: 379–381
- Barrett S. P., Gleeson P. A., de Silva H., Toh B. H., van Driel I. R. “Interferon-gamma is required during the initiation of an organ-specific autoimmune disease”. Eur. J. Immunol. 1996; 26: 1652–1655
- Koo G. C., Peppard J. R. “Establishment of monoclonal anti-Nk-1.1 antibody”. Hybridoma 1984; 3: 301–303
- Goding J. W. Monoclonal antibodies: principles and practice. Academic Press, Sydney 1986
- Seaman W. E., Blackman M. A., Gindhart T. D., Roubinian J. R., Loeb J. M., Talal N. “Beta-Estradiol reduces natural killer cells in mice”. J. Immunol. 1978; 121: 2193–2198
- Alderuccio R., Toh B. H., Tan S. S., Gleeson P. A., van Driel I. R. “An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus”. J. Exp. Med. 1993; 178: 419–426
- Trinchieri G. “Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity”. Annu. Rev. Immunol. 1995; 13: 251–276
- Silveira P. A., Baxter A. G., Cain W. E., van Driel I. R. “A major linkage region on distal chromosome 4confers susceptibility to mouse autoimmune gastritis”. J Immunol 1999; 162: 5106–5111
- Bendelac A. “Mouse NK1+ T cells”. Curr. Opin. Immunol. 1995; 7: 367–374
- Hammond K., Cain W., van Driel I., Godfrey D. “Three day neonatal thymectomy selectively depletes NK1.1+ T cells”. Int. Immunol. 1998; 10: 1491–1499
- Stoneman E. R., Bennett M., An J., Chesnut K. A., Wake-Land E. K., Scheerer J. B., Siciliano M. J., Kumar V., Mathew P. A. “Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells”. J. Exp. Med. 1995; 182: 305–313
- Munder M., Mallo M., Eichmann K., Modolell M. “Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation”. J. Exp. Med. 1998; 187: 2103–2108
- La Gruta N. L., van Driel I. R., Gleeson P. A. “Peripheral T cell expansion in lymphopenic mice results in a restricted T cell repertoire”. Eur. J. Immunol. 2000; 30: 3380–3386